Renal Trials & Guidelines

Landmark Renal Trials & Guidelines is a comprehensive, offline-ready clinical reference app for nephrologists, renal nurses, and trainees.

CONTENT INCLUDES:
• 159+ landmark clinical trials with full detail: population, intervention, primary endpoint, key results, and clinical impact
• KDIGO, KDOQI, UKKA, ISPD, BTS, and ABCD guideline summaries
• Key practice points and graded recommendations
• Categories: Anaemia, Blood Pressure, Diabetes & CKD, SGLT2 Inhibitors, Lipids, Dialysis, IgA Nephropathy, Lupus Nephritis, ANCA Vasculitis, Membranous Nephropathy

FEATURES:
• Works offline — no internet required after first load
• Full-text search across all trials and guidelines
• Filter by guideline organisation
• Evidence grades displayed (1A, 1B, 2C, etc.)
• Each trial links directly to its PubMed citation
• Optimised for both phone and tablet

Intended for use by qualified healthcare professionals as a quick reference tool. Always verify information against current institutional guidelines and exercise professional clinical judgement.

Recent changes:
• A cleaner new look with clearer cards.
• 8 new dialysis and critical-care trials: MyTEMP, RICH, SODa-BIC, LOCK-IT-100, LANDMARK, J-DAVID, HDPAL and NCDS.
• 6 new BTS transplant guidelines, including APOL1 donor testing, the failing graft, imlifidase and CMV.
• KDIGO drafts: 2027 CKD medications update and 2026 Diabetes in CKD.
• KDIGO Hepatitis C updated to 2022; UKKA hyperkalaemia to July 2026.
• Quiz questions for every new trial and guideline.